Our website use cookies to improve and personalize your experience and to display advertisements (if any). Our website may also include cookies from third parties like Google Adsense, Google Analytics, and Youtube. By using the website, you consent to the use of cookies.

Moderna to supply vaccines to Botswana

Moderna to supply vaccines to Botswana

MODERNA Inc has entered a supply agreement with the Botswana government for its COVID-19 vaccine. The Botswana Medicines Regulatory Authority (BMRA) has issued an emergency use authorization for the vaccine, Moderna said. The latest agreement is separate from the 500 million vaccine doses, which Moderna has agreed to supply to the GAVI-led COVAX vaccine sharing scheme, the company said.
Read More
Moderna targets up to 3-billion shots in 2022

Moderna targets up to 3-billion shots in 2022

CARL O’DONNELL and JULIE STEENHUYSEN  MODERNA Inc said on Thursday it is boosting manufacturing capacity for its COVID-19 vaccine and expects to make up to 3 billion doses in 2022, more than twice its previous forecast. It also said it is increasing its expectations for 2021 vaccine production to between 800 million and 1 billion shots, raising the bottom of its range from 700 million. The final number of inoculations will depend on how many are lower-dose formulations for boosters and immunizations for children. Moderna shots currently deploy 100 micrograms of vaccine substance but some future shots may use only…
Read More
Vaccine appears to be effective against new variants

Vaccine appears to be effective against new variants

MORDENA Inc says ita COVID-19 vaccine produced virus-neutralizing antibodies in laboratory tests against new coronavirus variants found in the UK and South Africa. A two-dose regimen of the Moderna COVID-19 vaccine is expected to be protective against emerging strains detected to date, the company said. Moderna, however, said it would test a vaccine booster against the South Africa variant in pre-clinical trials to see if that would be more effective in boosting antibodies against the variant and other future variants. Although all viruses mutate constantly, scientists are concerned about the mutations discovered in Britain and South Africa because they are…
Read More
Pfizer, Moderna, AstraZeneca: Which COVID-19 vaccine could reach developing countries first?

Pfizer, Moderna, AstraZeneca: Which COVID-19 vaccine could reach developing countries first?

THIN LEI WIN BRITAIN has become the first country in the world to approve a coronavirus vaccine developed by Oxford University and AstraZeneca as it battles a major winter surge driven by a new, highly contagious variant of the virus. Britain has already ordered 100 million doses of the vaccine, and the government said it had accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to grant emergency authorisation. The approval is a vindication for a shot seen as essential for mass immunisations in the developing world as well as in Britain. In December, Britain began rolling…
Read More
WHO expects decisions on Pfizer, Moderna, AstraZeneca vaccines in weeks

WHO expects decisions on Pfizer, Moderna, AstraZeneca vaccines in weeks

THE World Health Organization expects to make decisions on whether to give emergency use approval to COVID-19 vaccines from Pfizer, Moderna and AstraZeneca in the coming weeks, its chief scientist has said. Soumya Swaminathan said the global health body could decide on Pfizer's vaccine candidate in the next "couple of weeks", and later said it could also review Moderna's and AstraZeneca's candidates in a few weeks. WHO approval could allow a vaccine to be deployed in some countries where national medical regulators have not yet been able to evaluate it. Swaminathan said at least 10 companies had expressed an interest…
Read More
EXPLAINER-When and how will COVID-19 vaccines become available?

EXPLAINER-When and how will COVID-19 vaccines become available?

JULIE STEENHUYSEN nad CARL O’DONNELL  BRITAIN has become the first Western country to approve a COVID-19 vaccine, jumping ahead of the United States and Europe after its regulator cleared a shot developed by Pfizer and BioNTech for emergency use in record time. Pfizer, with partner BioNTech SE, and rival Moderna have released trial data showing their COVID-19 vaccines to be about 95% effective at preventing the illness, while AstraZeneca last month said its vaccine was on average about 70% effective. The companies have said distribution could begin almost immediately after any approval, with governments around the world to decide who…
Read More
Q&A: Where are we in the COVID-19 vaccine race?

Q&A: Where are we in the COVID-19 vaccine race?

LARGE global trials of several COVID-19 vaccine candidates involving tens of thousands of participants are well underway with some having gathered sufficient data to seek emergency use authorisation. The following is what we know about the race to deliver vaccines to help end the coronavirus pandemic that has claimed more than 1.45 million lives worldwide: Who is furthest along? U.S. drugmaker Pfizer Inc and German partner BioNTech SE released a full late-stage trial data analysis on Nov. 18 that showed their shot was 95% effective at stopping COVID-19, the highest efficacy rate so far. U.S. pharmaceutical company Moderna released its…
Read More